Grifols says Haier Group still OK to buy stake in Shanghai RAAS

14 Jan 2024
Acquisition
The logo of the Spanish pharmaceuticals company Grifols is pictured on theirs facilities in Parets del Valles, north of Barcelona, Spain, January 9, 2024. REUTERS/Albert Gea/File Photo Acquire Licensing Rights, opens new tab
Reporting by Graham Keeley, editing by Inti Landauro, William Maclean and Christina Fincher
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Preview
Source: Reuters
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Preview
Source: Reuters
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Preview
Source: Reuters
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Preview
Source: Reuters
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Preview
Source: Reuters
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.